Ultragenyx Pharmaceutical, Inc. (RARE)
16.24
-0.03
(-0.18%)
USD |
NASDAQ |
Nov 13, 10:40
Ultragenyx Pharmaceutical Net Income (Annual) : -575.00M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -575.00M |
| December 31, 2024 | -569.18M |
| December 31, 2023 | -606.64M |
| December 31, 2022 | -707.42M |
| December 31, 2021 | -454.02M |
| December 31, 2020 | -186.57M |
| December 31, 2019 | -402.73M |
| December 31, 2018 | -197.61M |
| Date | Value |
|---|---|
| December 31, 2017 | -302.14M |
| December 31, 2016 | -245.87M |
| December 31, 2015 | -145.62M |
| December 31, 2014 | -59.80M |
| December 31, 2013 | -35.07M |
| December 31, 2012 | -19.56M |
| December 31, 2011 | -7.466M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Ionis Pharmaceuticals, Inc. | -381.39M |
| AbbVie, Inc. | 4.193B |
| Krystal Biotech, Inc. | 204.83M |
| BridgeBio Pharma, Inc. | -732.94M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |